Andrew Trainer

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 243 citations

Medicine, Oncology, Pharmacology +13

WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation ^® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia

Peter Gilling, Neil Barber, Mohamed Bidair et al. · The Journal of Urology · 2018 · 232 citations

Medicine, Surgery, Urology +17

IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer

Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky et al. · NEJM Evidence · 2022 · 158 citations

Medicine, Oncology, Pharmacology +16

Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer

F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace et al. · European Urology · 2018 · 92 citations

Medicine, Oncology, Urology +15